NCCN VERSION 2 2015

148 / 188

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-73
NCCN Guidelines Index
Breast Cancer Table of Contents
Discussion
NCCN Guidelines Version 2.2015
Breast Cancer
88. Sukumvanich P, Case LD, Van Zee K, et al. Incidence and time
course of bleeding after long-term amenorrhea after breast cancer
treatment: a prospective study. Cancer 2010;116:3102-3111. Available
at:
89. Peate M, Meiser B, Friedlander M, et al. It's now or never: fertility-
related knowledge, decision-making preferences, and treatment
intentions in young women with breast cancer--an Australian fertility
decision aid collaborative group study. J Clin Oncol 2011;29:1670-1677.
Available at: .
90. Baseline staging tests in primary breast cancer: Practice guideline
report # 1-14: Members of the Breast Cancer Disease Site Group.
Available at:
&path=/File%20Database/CCO%20Files/PEBC/pebc1-14f.pdf
Accessed: March, 2014.
91. Puglisi F, Follador A, Minisini AM, et al. Baseline staging tests after
a new diagnosis of breast cancer: further evidence of their limited
indications. Ann Oncol 2005;16:263-266. Available at:
.
92. Carr CE, Conant EF, Rosen MA, et al. The impact of FDG PET in
the staging of breast cancer [abstract]. J Clin Oncol 2006;24:Abstract
530. Available at:
.
93. Khan QJ, O'Dea AP, Dusing R, et al. Integrated FDG-PET/CT for
initial staging of breast cancer [abstract]. J Clin Oncol 2007;25(Suppl
18):Abstract 558. Available at:
.
94. Kumar R, Chauhan A, Zhuang H, et al. Clinicopathologic factors
associated with false negative FDG-PET in primary breast cancer.
Breast Cancer Res Treat 2006;98:267-274. Available at:
.
95. Podoloff DA, Advani RH, Allred C, et al. NCCN task force report:
positron emission tomography (PET)/computed tomography (CT)
scanning in cancer. J Natl Compr Canc Netw 2007;5 Suppl 1:1-1.
Available at: .
96. Rosen EL, Eubank WB, Mankoff DA. FDG PET, PET/CT, and
breast cancer imaging. Radiographics 2007;27 Suppl 1:S215-229.
Available at: .
97. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG. Prospective
multicenter study of axillary nodal staging by positron emission
tomography in breast cancer: a report of the staging breast cancer with
PET Study Group. J Clin Oncol 2004;22:277-285. Available at:
.
98. Arriagada R, Le MG, Rochard F, Contesso G. Conservative
treatment versus mastectomy in early breast cancer: patterns of failure
with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer
Group. J Clin Oncol 1996;14:1558-1564. Available at:
99. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of
differences in the extent of surgery for early breast cancer on local
recurrence and 15-year survival: an overview of the randomised trials.
Lancet 2005;366:2087-2106. Available at:
.
100. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a
randomized trial comparing total mastectomy, lumpectomy, and
lumpectomy plus irradiation for the treatment of invasive breast cancer.
N Engl J Med 2002;347:1233-1241. Available at:
101. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of
a randomized study comparing breast-conserving surgery with radical
mastectomy for early breast cancer. N Engl J Med 2002;347:1227-
1232. Available at: